HomeCompareRPHCF vs PM

RPHCF vs PM: Dividend Comparison 2026

RPHCF yields 1.82% · PM yields 3.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RPHCF wins by $43.18M in total portfolio value· pulled ahead in Year 4
10 years
RPHCF
RPHCF
● Live price
1.82%
Share price
$15.20
Annual div
$0.28
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.23M
Annual income
$39,107,153.37
Full RPHCF calculator →
PM
Philip Morris International
● Live price
3.49%
Share price
$164.83
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,502.61
Full PM calculator →

Portfolio growth — RPHCF vs PM

📍 RPHCF pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRPHCFPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RPHCF + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RPHCF pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RPHCF
Annual income on $10K today (after 15% tax)
$154.90/yr
After 10yr DRIP, annual income (after tax)
$33,241,080.36/yr
PM
Annual income on $10K today (after 15% tax)
$297.03/yr
After 10yr DRIP, annual income (after tax)
$2,127.22/yr
At 15% tax rate, RPHCF beats the other by $33,238,953.15/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RPHCF + PM for your $10,000?

RPHCF: 50%PM: 50%
100% PM50/50100% RPHCF
Portfolio after 10yr
$21.64M
Annual income
$19,554,828.00/yr
Blended yield
90.37%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

RPHCF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
4.2
Piotroski
5/9
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.9% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RPHCF buys
0
PM buys
0
No recent congressional trades found for RPHCF or PM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRPHCFPM
Forward yield1.82%3.49%
Annual dividend / share$0.28$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%17.2%
Portfolio after 10y$43.23M$49.6K
Annual income after 10y$39,107,153.37$2,502.61
Total dividends collected$42.89M$11.8K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: RPHCF vs PM ($10,000, DRIP)

YearRPHCF PortfolioRPHCF Income/yrPM PortfolioPM Income/yrGap
1$11,064$364.47$11,650$409.56$586.00PM
2$12,593$753.78$13,592$497.49$999.00PM
3$15,078$1,603.54$15,882$605.21$804.00PM
4← crossover$19,722$3,588.75$18,589$737.41+$1.1KRPHCF
5$29,877$8,774.08$21,794$899.94+$8.1KRPHCF
6$56,812$24,844.41$25,597$1,100.16+$31.2KRPHCF
7$149,094$88,305.24$30,118$1,347.30+$119.0KRPHCF
8$592,694$433,162.94$35,505$1,652.97+$557.2KRPHCF
9$3,852,779$3,218,596.09$41,940$2,031.88+$3.81MRPHCF
10$43,229,627$39,107,153.37$49,643$2,502.61+$43.18MRPHCF

RPHCF vs PM: Complete Analysis 2026

RPHCFStock

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin; medicine for internal use, such as digestive and herbal medicines; oral medicines comprising gastrointestinal medicines, herbal medicines, and supplements; non-prescription medicines; and beauty counters that provide beauty and health services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. Rohto Pharmaceutical Co.,Ltd. was founded in 1899 and is headquartered in Osaka, Japan.

Full RPHCF Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this RPHCF vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RPHCF vs SCHDRPHCF vs JEPIRPHCF vs ORPHCF vs KORPHCF vs MAINRPHCF vs MORPHCF vs BTIRPHCF vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.